Teniposide (VM-26)- and etoposide (VP-16-213)-induced augmentation of methotrexate transport and polyglutamylation in Ehrlich ascites tumor cells in vitro.
D000818:Animals; D001692:Biological Transport / Q000187:drug effects; D002286:Carcinoma, Ehrlich Tumor; D002478:Cells, Cultured; D002712:Chlorides / Q000378:metabolism; D005047:Etoposide / Q000494:pharmacology*; D005947:Glucose / Q000494:pharmacology; D007700:Kinetics; D008727:Methotrexate / Q000031:analogs & derivatives* / Q000378:metabolism*; D051379:Mice; D010455:Peptides / Q000378:metabolism*; D011034:Podophyllotoxin / Q000031:analogs & derivatives*; D011099:Polyglutamic Acid / Q000031:analogs & derivatives / Q000378:metabolism*; D013713:Teniposide / Q000494:pharmacology*; D014750:Vincristine / Q000494:pharmacology; D014867:Water / Q000378:metabolism
D002712:Chlorides; D010455:Peptides; D014867:Water; D011099:Polyglutamic Acid; D014750:Vincristine; D005047:Etoposide; C014085:methotrexate polyglutamate; D013713:Teniposide; D005947:Glucose; D011034:Podophyllotoxin; D008727:Methotrexate